QuickView for Tumour necrosis factor domain (biogroup)

1. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
2. CD4+ T-lymphocytes activated with anti-CD3 and anti-CD28 Ab in presence of progesterone
3. L1000 CMAP - Umbilical vein endothelial HUVEC cells treated with small molecule perturbagens
4. L1000 CMAP - Hepatocellular carcinoma HEPG2 cells treated with small molecule perturbagens
5. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (2 of 4)

There were no matches for Tumour necrosis factor domain

1. The Role of C1q Tumor Necrosis Factor-related Protein 6 in Breast Cancer
2. A Study to Evaluate the Safety and Efficacy of MabThera (Rituximab) in Combination With Methotrexate…
3. Human Anti-tumor Necrosis Factor (TNF) Monoclonal Antibody Adalimumab in Subjects With Active Ankylo…
4. To Observe the Impacts of Anti-Tumor Necrosis Factor (TNF) Effectiveness on Improvement in Work Plac…
5. An Extension to Study MA21573, Evaluating Tocilizumab in Patients With Active Rheumatoid Arthritis a…